What is GW-0742 (Cardarine 2.0)?
GW-0742 is a second-generation peroxisome proliferator-activated receptor delta (PPARδ) agonist representing significant advancement in metabolic research compounds. Developed as an improved analogue of GW-501516, this pharmaceutical-grade compound exhibits enhanced receptor selectivity and increased potency in laboratory investigations. Research scientists at Stroid UK Shop utilise GW-0742 to examine advanced metabolic pathways and cellular energy expenditure mechanisms in controlled experimental environments.
Laboratory Applications in Metabolic Research
Research teams investigate GW-0742’s modulation of fatty acid oxidation pathways and mitochondrial biogenesis in cellular models. This compound demonstrates superior PPARδ activation compared to first-generation analogues, making it valuable for studying metabolic flexibility and substrate utilisation patterns. Scientists examine its effects on gene expression related to energy metabolism, particularly in muscle and adipose tissue research. The compound’s enhanced pharmacokinetic profile enables more precise experimental protocols in metabolic syndrome research models. Laboratories specialising in PPARδ agonist studies employ GW-0742 to investigate cellular energy homeostasis mechanisms and oxidative metabolism pathways.
Technical Specifications
| Property | Value |
|---|---|
| Chemical Name | GW-0742 |
| Alternative Names | Cardarine 2.0 |
| CAS Number | 317318-84-6 |
| Molecular Formula | C21H17F4NO3S2 |
| Molecular Weight | 471.49 g/mol |
| Purity | ≥98% (HPLC) |
| Storage | Room temperature, protect from light |
| Solubility | DMSO, ethanol |
This pharmaceutical preparation undergoes rigorous quality control testing to ensure consistent research outcomes. Research facilities studying selective receptor modulators and metabolic research compounds require high-purity standards for reliable experimental data generation.
Research-Only Compliance
GW-0742 Advanced Cardio Pharmaceutical is manufactured exclusively for in-vitro laboratory research purposes. This compound is not intended for human consumption, therapeutic applications, or any use outside controlled scientific investigations. Research institutions must ensure appropriate safety protocols and regulatory compliance when handling this experimental compound. All studies should follow established laboratory guidelines for chemical research and waste disposal procedures.
